Business Insights, April 2008, Pages: 265
Business Insight's New Report Findings: Biomarkers are being developed to identify a disease and/or determine its course (biomarkers of disease), evaluate ...
Decision Resources, Inc., Oct 2005, Pages: 15
Biotechnology and pharmaceutical companies are increasingly looking to biomarkers to help them increase R&D productivity and clinical trial success rates. They. ...
Decision Resources, Inc., Dec 2008, Pages: 39
Predictive safety biomarkers are categorized by their target action?predicting drug toxicity, selecting patients for treatment, or predicting treatment effi ...
Decision Resources, Inc., April 2007, Pages: 34
Although novel cancer biomarkers are reported on a weekly basis, only a handful are actually translated into fully validated diagnostic tools. ...
Decision Resources, Inc., June 2005, Pages: 13
Biomarkers have the potential to play a valuable role in simplifying the pharmaceutical development process. They can be used to ...
Decision Resources, Inc., Oct 2007, Pages: 19
... as possible. The use of biomarkers. 566767, Can the Use of Biomarkers as Surrogate End Points Stimulate the Drug-Development Lull? ...
Decision Resources, Inc., Dec 2006, Pages: 27
363595, Toxicity Biomarkers: Promising Tools for Accelerated Drug Development, In the wake of several notorious drug withdrawals caused by unsuspected toxicities ...
Frost & Sullivan, Oct 2004 Biomarkers to Play a Key Role in Tackling Failure Rates in Clinical Trials Biomarkers are emerging as an essential tool to boost efficiency in the field of dr. ...
Decision Resources, Inc., May 2008, Pages: 32
Introduction Demographic and cost data provide clear reasons for pharmaceutical industry investment in CVD biomarkers and diagnostics. CVDs are highly prevalen. ...
Fuji-Keizai USA, Inc., Aug 2004, Pages: 202
This report is about the market for molecular biomarkers for clinical diagnostics and for drug discovery and development. The research ...
Decision Resources, Inc., Dec 2008, Pages: 33
680505, Enabling Oncology Diagnostics: Predictive Biomarkers Based on Genes, Proteins, and Pathways, Introduction In efforts to find new ways to transform the ...
Decision Resources, Inc., Dec 2008, Pages: 35
Introduction Biomarkers?physical characteristics that are objectively evaluated as indicators of normal biological processes, pathogenic processes, or ...
Espicom Business Intelligence Ltd, Aug 2008, Pages: 120
Part of our new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cardiovascular biomarker ...
Decision Resources, Inc., Oct 2007, Pages: 28
As health care moves toward personalized medicine, biomarkers have gained an increasingly important role in the delivery of efficient, quality care. ...
Decision Resources, Inc., July 2006, Pages: 25
344048, Emerging Diagnostic Biomarkers in Ovarian Cancer, Worldwide, ovarian cancer (CaO) is the leading cause of death from gynecological cancer and the fourth ...
Decision Resources, Inc., Nov 2006, Pages: 32
362272, Parkinson's Disease Biomarkers: Vital Tools for Neuroprotectants, Parkinson?s disease (PD) is poised to become a significant public health burden ...
Takeda Pacific, July 2005, Pages: 168
One of the big ideas that emerged since the completion of the human genome project involves new biomarkers and tests used for tailoring new drugs that match an. ...
Datamonitor, May 2006, Pages: 73
339284, Cancer Biomarkers: Enhancing Diagnostic, Therapeutic and Developmental Strategies, The current focus on biomarker discovery is a result of an improved ...
Frost & Sullivan, March 2007
This Frost & Sullivan research service titled Advances in Biomarkers provides an overview of emerging technologies and their applications in disease diagnosis,. ...
BioPharm Reports (VennBio Ltd.), Jan 2009, Pages: 98
This report gives a comprehensive and up-to-date review of Alzheimer's disease biomarkers. Recent years have seen significant advances in this field. ...
